Reaction Details Report a problem with these data
Target
Sepiapterin reductase
Ligand
BDBM660244
Substrate
n/a
Meas. Tech.
Measurement of Human SPR Inhibitory Activity Assay
IC50
0.640±n/a nM
Citation
KAMAURA, M; INABA, Y; SHINTANI, Y; KUWANO, Y; NAKAO, M; NAGAI, H; KUROSE, N; TAKAYA, K; NAKAJIMA, M CONDENSED HETEROCYCLIC COMPOUND US Patent US20240092784 Publication Date 3/21/2024
More Info.:
Target
Name:
Sepiapterin reductase
Synonyms:
SPR | SPRE_HUMAN | Sepiapterin reductase (SPR)
Type:
Enzyme
Mol. Mass.:
28050.66
Organism:
Homo sapiens (Human)
Description:
P35270
Residue:
261
Sequence:
MEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSGLRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQVNNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDMLFQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQKLLSLLEKDEFKSGAHVDFYDK
Inhibitor
Name:
BDBM660244
Synonyms:
(E)-3-(3-((Cyanomethyl)(methyl)amino)-3-oxoprop-1-en-1-yl)-N-cyclopropyl-7-hydroxy-4-isobutyl-2-methyl-5-oxo-4,5-dihydropyrazolo[1,5-a]pyrimidine-6-carboxamide | US20240092784, Example 681
Type:
Small organic molecule
Emp. Form.:
C21H26N6O4
Mol. Mass.:
426.4689
SMILES:
CC(C)Cn1c2c(\C=C\C(=O)N(C)CC#N)c(C)nn2c(O)c(C(=O)NC2CC2)c1=O